Document is current
Any future updates will be listed below
-
Authors
Uemura, Hiroji https://orcid.org/0000-0001-7943-1564
Kobayashi, Kazuki
Yokomizo, Akira
Hinotsu, Shiro
Horie, Shigeo
Kakehi, Yoshiyuki
Nonomura, Norio
Ogawa, Osamu
Oya, Mototsugu
Suzuki, Kazuhiro
Saito, Atsushi
Asakawa, Keiko
Uno, Satoshi
Naito, Seiji
-
Funding
Funding for this research was provided by:
Astellas Pharma Inc.
Pfizer Inc.
- License Information
-
More Information
Article History
Received: 19 April 2022
Accepted: 12 July 2022
First Online: 10 August 2022
Declarations
:
: HU, YK, and SN received personal fees from Astellas during the conduct of the study. KK and SHi served as study investigators during the conduct of the study. AY received honoraria from Astellas, Bayer, and Sanofi. SHo received personal fees from Astellas, honoraria from Astellas, Bayer, Kissel, Kyourin, Nihon Kayaku, Nippon Shinyaku, Pfizer, and Sanofi, and consulting fees from Astellas and Angfa. NN received honoraria from Astellas, AstraZeneca, Bayer, Janssen, Nippon Shinyaku, and Takeda. OO has no conflicts of interest to declare. MO received honoraria from Astellas, AstraZeneca, Bayer, Janssen, Merck, Sharp & Dohme, Sanofi, and Takeda, research funding from Astellas, and scholarship donations from Sanofi, Takeda, and Bayer. KS received honoraria from Astellas, AstraZeneca, Bayer, and Sanofi. AS is an employee and stockholder in Astellas. KA and SU are employees of Astellas.
